Yuki Taya

627 total citations
38 papers, 366 citations indexed

About

Yuki Taya is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Yuki Taya has authored 38 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Yuki Taya's work include Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Yuki Taya is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Acute Myeloid Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Yuki Taya collaborates with scholars based in Japan, United States and Sri Lanka. Yuki Taya's co-authors include Toshinori Ozaki, K Murakami, Masafumi Saijo, Hiroshi Watarai, Satoshi Yamazaki, Masataka Kasai, Hiromitsu Nakauchi, Yasunori Ota, Adam C. Wilkinson and Shuichi Taniguchi and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuki Taya

26 papers receiving 364 citations

Peers

Countries citing papers authored by Yuki Taya

Since Specialization

Citations

This map shows the geographic impact of Yuki Taya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Taya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Taya more than expected).

Fields of papers citing papers by Yuki Taya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Taya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Taya. The network helps show where Yuki Taya may publish in the future.

Co-authorship network of co-authors of Yuki Taya

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Taya. A scholar is included among the top collaborators of Yuki Taya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Taya. Yuki Taya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma in a nonagenarian patient 2026 ·Journal of Clinical and Experimental Hematopathology ·Junkoh Yamamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Yuki Taya, (unknown), Shinsuke Takagi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Treatment of post-transplant lymphoproliferative disorders in kidney transplant recipients: a single-center retrospective analysis 2025 ·International Journal of Hematology ·(unknown), Daisuke Kaji, (unknown), (unknown), (unknown), Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Yuki Asano‐Mori, Naoyuki Uchida, Atsushi Wake, Go Yamamoto	0
3	Therapy-related Trilineage Mixed Phenotype Acute Leukemia Treated with Venetoclax and Azacitidine 2025 ·Internal Medicine ·Johtaro Yamamoto, (unknown), (unknown), (unknown), Yuki Taya, Daisuke Kaji, Aya Nishida, Hironori Uruga, Shinsuke Takagi, Kazuya Ishiwata, Hisashi Yamamoto, Akiko Masuda, Yutaka Takazawa, Go Yamamoto, (unknown), Naoyuki Uchida, (unknown)	0
4	Lymphocyte Crossmatch Testing or Donor HLA-DP and -DQ Allele Typing Effectiveness in Single Cord Blood Transplantation for Patients With Anti-HLA Antibodies Other Than Against HLA-A, -B, -C, and -DRB1 2024 ·Transplantation and Cellular Therapy ·Makoto Osada, Hisashi Yamamoto, (unknown), (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Shigeyoshi Makino, Yuki Asano‐Mori, Go Yamamoto, Shuichi Taniguchi, Atsushi Wake, Naoyuki Uchida	2
5	A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia 2024 ·International Journal of Hematology ·(unknown), Shinsuke Takagi, (unknown), Shin‐ichi Tsunoda, (unknown), (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Hisashi Yamamoto, Go Yamamoto, Yuki Asano‐Mori, (unknown), Shigeyoshi Makino, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida	0
6	What Is the Optimal Dose of MMF in Single Cord Blood Transplantation?: A Single-Center Analysis of MMF Dosage for GVHD Prophylaxis and Its Impact on Outcomes 2024 ·Blood ·Johtaro Yamamoto, Hisashi Yamamoto, (unknown), (unknown), (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Shinsuke Takagi, Kazuya Ishiwata, Go Yamamoto, Yuki Asano‐Mori, Atsushi Wake, Naoyuki Uchida	0
7	Rituximab/bendamustine/cytarabine for transplant‐eligible patients with mantle cell lymphoma: A retrospective study 2023 ·Cancer Medicine ·(unknown), Daisuke Kaji, (unknown), (unknown), (unknown), Yuki Taya, (unknown), Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, (unknown), Atsushi Wake, Naoyuki Uchida, Shuichi Taniguchi, Go Yamamoto	1
8	Single CBT As 2nd Allo-SCT Is Promising for Selected Patients with Relapsed Hematopoietic Malignancies 2023 ·Blood ·(unknown), Hisashi Yamamoto, (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Go Yamamoto, Atsushi Wake, Naoyuki Uchida	1
9	Efficacy of Lisocabtagene Maraleucel for Relapsed or Refractory Aggressive B Cell Lymphoma in Our Hospital 2023 ·Blood ·Daisuke Kaji, (unknown), (unknown), (unknown), Yuki Taya, Aya Nishida, Shinsuke Takagi, Hisashi Yamamoto, Kazuya Ishiwata, Yuki Asano‐Mori, Atsushi Wake, Naoyuki Uchida, Go Yamamoto	0
10	Utility of liver stiffness measurement in the diagnosis of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation 2023 ·Journal of Medical Ultrasonics ·(unknown), Satoshi Saitoh, (unknown), (unknown), Koichi Kubota, Yuki Taya, Atsushi Wake, Akiko Masuda, Kazuya Ishiwata	3
11	Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity 2023 ·Molecules ·Yuki Taya, (unknown), Shunsuke Nakao, (unknown), Naoki Shimizu, Yukihiro Nomura, Kiyotaka Nakagawa	3
12	Natto consumption suppresses atherosclerotic plaque progression in LDL receptor-deficient mice transplanted with iRFP-expressing hematopoietic cells 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Michito Hamada, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bryan J. Mathis, Nozomu Obana, Shinji Fukuda, Satoru Takahashi, Yuki Taya, Satoshi Sakai, Yuji Hiramatsu	1
13	Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies 2023 ·Annals of Hematology ·(unknown), Muneyoshi Kimura, Shinsuke Takagi, (unknown), (unknown), (unknown), (unknown), Mitsuhiro Yuasa, Daisuke Kaji, (unknown), Yuki Taya, Aya Nishida, Kazuya Ishiwata, Hisashi Yamamoto, Go Yamamoto, Yuki Asano‐Mori, Atsushi Wake, Naoyuki Uchida, Shuichi Taniguchi, Hideki Araoka	1
14	Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients 2022 ·International Journal of Hematology ·Takashi Oyama, (unknown), Hideki Araoka, (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Yuki Asano‐Mori, Naoyuki Uchida, Atsushi Wake, Shigeyoshi Makino, Shuichi Taniguchi	2
15	Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation 2021 ·British Journal of Haematology ·Mitsuhiro Yuasa, Yuki Asano‐Mori, (unknown), (unknown), (unknown), Daisuke Kaji, Yuki Taya, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Hisashi Yamamoto, Go Yamamoto, Hideki Araoka, Atsushi Wake, Shigeyoshi Makino, (unknown), Naoyuki Uchida, Shuichi Taniguchi	2
16	Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis 2020 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Muneyoshi Kimura, Shinsuke Takagi, (unknown), Mitsuhiro Yuasa, (unknown), Daisuke Kaji, Aya Nishida, Yuki Taya, Kazuya Ishiwata, Hisashi Yamamoto, Yuki Asano‐Mori, Go Yamamoto, Naoyuki Uchida, Atsushi Wake, Shuichi Taniguchi, Hideki Araoka	8
17	Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation 2020 ·Transplantation and Cellular Therapy ·Muneyoshi Kimura, Hisashi Yamamoto, Naoyuki Uchida, (unknown), (unknown), (unknown), Mitsuhiro Yuasa, Daisuke Kaji, (unknown), Aya Nishida, Yuki Taya, Kazuya Ishiwata, Shinsuke Takagi, Go Yamamoto, Yuki Asano‐Mori, Atsushi Wake, Shuichi Taniguchi, Hideki Araoka	2
18	Dissecting the valine dependency of hematopoietic stem cell function 2017 ·Experimental Hematology ·Adam C. Wilkinson, Yuki Taya, Satoshi Yamazaki, Hiromitsu Nakauchi	2
19	Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation 2016 ·Science ·Yuki Taya, Yasunori Ota, Adam C. Wilkinson, (unknown), Hiroshi Watarai, Masataka Kasai, Hiromitsu Nakauchi, Satoshi Yamazaki	140
20	Pneumothorax in an Early Phase after Allogeneic Hematopoietic Stem Cell Transplantation 2013 ·SHILAP Revista de lepidopterología ·Yasuhiro Ebihara, Shohei Yamamoto, Shinji Mochizuki, (unknown), Yuki Taya, Toshiro Kawakita, Seiko Kato, Jun Ooi, Satoshi Takahashi, Arinobu Tojo, Kohichiro Tsuji	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact